Axon Enterprise (NASDAQ:AXON) Price Target Cut to $675.00 by Analysts at Morgan Stanley

Axon Enterprise (NASDAQ:AXON) had its price objective lowered by Morgan Stanley from $713.00 to $675.00 in a research note published on Wednesday,Benzinga reports. Morgan Stanley currently has an overweight rating on the biotechnology company’s stock.

Several other research analysts have also commented on AXON. William Blair restated an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, February 3rd. The Goldman Sachs Group decreased their price objective on shares of Axon Enterprise from $940.00 to $800.00 and set a “buy” rating for the company in a report on Wednesday, November 5th. Needham & Company LLC cut their target price on Axon Enterprise from $870.00 to $600.00 and set a “buy” rating on the stock in a report on Friday, February 20th. Barclays reduced their price target on Axon Enterprise from $702.00 to $682.00 and set an “overweight” rating for the company in a research report on Wednesday. Finally, Wall Street Zen lowered Axon Enterprise from a “hold” rating to a “sell” rating in a report on Saturday, November 8th. Sixteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, Axon Enterprise presently has an average rating of “Moderate Buy” and an average target price of $762.93.

Axon Enterprise Stock Performance

Shares of NASDAQ AXON opened at $520.18 on Wednesday. The company has a debt-to-equity ratio of 0.57, a current ratio of 3.12 and a quick ratio of 2.89. Axon Enterprise has a one year low of $396.41 and a one year high of $885.91. The business’s 50-day moving average price is $539.22 and its two-hundred day moving average price is $628.00. The company has a market capitalization of $41.05 billion, a P/E ratio of 342.23, a price-to-earnings-growth ratio of 13.33 and a beta of 1.48.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings results on Tuesday, February 24th. The biotechnology company reported $2.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.60 by $0.55. The business had revenue of $796.72 million during the quarter, compared to analyst estimates of $755.29 million. Axon Enterprise had a return on equity of 2.94% and a net margin of 4.48%.The firm’s revenue was up 38.5% on a year-over-year basis. During the same period in the previous year, the company earned $2.08 EPS. Analysts anticipate that Axon Enterprise will post 5.8 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, President Joshua Isner sold 20,000 shares of the company’s stock in a transaction on Monday, December 8th. The shares were sold at an average price of $552.60, for a total transaction of $11,052,000.00. Following the completion of the transaction, the president directly owned 249,502 shares in the company, valued at $137,874,805.20. This represents a 7.42% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Jeri Williams sold 100 shares of the stock in a transaction on Thursday, December 4th. The shares were sold at an average price of $550.63, for a total transaction of $55,063.00. Following the completion of the sale, the director directly owned 1,316 shares of the company’s stock, valued at approximately $724,629.08. This trade represents a 7.06% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 48,040 shares of company stock valued at $27,249,338 in the last ninety days. Company insiders own 4.40% of the company’s stock.

Institutional Investors Weigh In On Axon Enterprise

Several hedge funds have recently made changes to their positions in the stock. Westside Investment Management Inc. raised its holdings in Axon Enterprise by 4.8% in the 2nd quarter. Westside Investment Management Inc. now owns 283 shares of the biotechnology company’s stock valued at $225,000 after acquiring an additional 13 shares in the last quarter. Newbridge Financial Services Group Inc. increased its position in shares of Axon Enterprise by 2.8% during the second quarter. Newbridge Financial Services Group Inc. now owns 508 shares of the biotechnology company’s stock valued at $421,000 after purchasing an additional 14 shares during the period. Vicus Capital raised its stake in shares of Axon Enterprise by 3.7% in the third quarter. Vicus Capital now owns 396 shares of the biotechnology company’s stock valued at $284,000 after purchasing an additional 14 shares in the last quarter. Evergreen Capital Management LLC lifted its position in Axon Enterprise by 3.8% in the second quarter. Evergreen Capital Management LLC now owns 413 shares of the biotechnology company’s stock worth $342,000 after purchasing an additional 15 shares during the period. Finally, STF Management LP boosted its stake in Axon Enterprise by 1.4% during the second quarter. STF Management LP now owns 1,164 shares of the biotechnology company’s stock worth $964,000 after buying an additional 16 shares in the last quarter. Institutional investors own 79.08% of the company’s stock.

More Axon Enterprise News

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Q4 beat and raised medium/long-term targets — Axon reported $796.7–797M in Q4 revenue (≈+39% YoY) and $2.15 adjusted EPS, beat consensus, issued 2026 revenue guidance well above street estimates and introduced $6B 2028 revenue/strong margin targets. This is the headline catalyst for the rally. Axon reports Q4 2025 revenue of $797 million
• Positive Sentiment: AI is driving bookings and product demand — Management emphasized AI features across cameras, license-plate readers and evidence management that are accelerating deployments and bookings, helping convert device customers into higher‑margin software subscribers. Taser Maker Axon Says Its Business Is Being ‘Supercharged by AI.’
• Positive Sentiment: Government spending and enterprise demand tailwinds — Reports cite strong device and software demand from federal and public‑safety customers (including DHS initiatives) that support the company’s growth runway. Axon shares rise as Taser-maker’s profit gets boost from government spending
• Positive Sentiment: Some sell‑side firms maintain buy ratings — Several analysts reiterated bullish views or maintained Buy ratings based on the AI-driven platform and long-term targets, supporting the upside narrative. Axon: AI-Driven Platform Strength and Long-Term Growth Targets Support Buy Rating
• Neutral Sentiment: Earnings call and presentation available — Full Q4 earnings call transcript and slides were posted; useful for digging into bookings, margin cadence and product adoption metrics. Axon Enterprise, Inc. (AXON) Q4 2025 Earnings Call Transcript
• Neutral Sentiment: Short‑interest data reported but inconclusive — A February short‑interest entry shows zero/NaN values and a 0.0 days ratio, which appears to be a data anomaly and shouldn’t be treated as meaningful without confirmation from exchange filings.
• Negative Sentiment: Analysts trimmed price targets despite the beat — Several firms cut targets after the print (UBS, Barclays, Morgan Stanley, Piper Sandler noted cuts in coverage summaries), which can moderate upside expectations even though many kept overweight/buy ratings. These Analysts Cut Their Forecasts On Axon After Q4 Results

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.